Adalat Gits 30 en es it fr

Adalat Gits 30 Brand names, Adalat Gits 30 Analogs

Adalat Gits 30 Brand Names Mixture

  • No information avaliable

Adalat Gits 30 Chemical_Formula


Adalat Gits 30 RX_link

Adalat Gits 30 fda sheet

Adalat_Gits_30 FDA

Adalat Gits 30 msds (material safety sheet)

Adalat_Gits_30 MSDS

Adalat Gits 30 Synthesis Reference

Bossert, Vater, U.S. Pat. 3,485,847 (1969)

Adalat Gits 30 Molecular Weight

346.335 g/mol

Adalat Gits 30 Melting Point

172 - 174 oC

Adalat Gits 30 H2O Solubility


Adalat Gits 30 State


Adalat Gits 30 LogP


Adalat Gits 30 Dosage Forms

Capsule; Tablet; Tablet (extended-release)

Adalat Gits 30 Indication

For the management of vasospastic angina, chronic stable angina and hypertension.

Adalat Gits 30 Pharmacology

Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.

Adalat Gits 30 Absorption

Rapidly and fully absorbed following oral administration.

Adalat Gits 30 side effects and Toxicity

Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)

Adalat Gits 30 Patient Information

Adalat Gits 30 Organisms Affected

Humans and other mammals